BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37016095)

  • 21. Integrated analysis of miRNA-mRNA networks reveals a strong anti-skin cancer signature in vitiligo epidermis.
    Singh A; Gupta A; Chowdhary M; Brahmbhatt HD
    Exp Dermatol; 2021 Sep; 30(9):1309-1319. PubMed ID: 33682215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs and potential target interactions in psoriasis.
    Zibert JR; Løvendorf MB; Litman T; Olsen J; Kaczkowski B; Skov L
    J Dermatol Sci; 2010 Jun; 58(3):177-85. PubMed ID: 20417062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of microRNAs in autoimmune diseases with skin involvement.
    Deng X; Su Y; Wu H; Wu R; Zhang P; Dai Y; Chan TM; Zhao M; Lu Q
    Scand J Immunol; 2015 Mar; 81(3):153-65. PubMed ID: 25430682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients.
    Zhang Z; Xu SX; Zhang FY; Yin XY; Yang S; Xiao FL; Du WH; Wang JF; Lv YM; Tang HY; Zhang XJ
    Arch Dermatol Res; 2009 Feb; 301(2):167-73. PubMed ID: 18839195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mannose-binding lectin gene polymorphism in psoriasis and vitiligo: an observational study and computational analysis.
    Behairy MY; Tawfik NZ; Eid RA; Nasser Binjawhar D; Alshaya DS; Fayad E; Elkhatib WF; Abdallah HY
    Front Med (Lausanne); 2023; 10():1340703. PubMed ID: 38404462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anatomically distinct fibroblast subsets determine skin autoimmune patterns.
    Xu Z; Chen D; Hu Y; Jiang K; Huang H; Du Y; Wu W; Wang J; Sui J; Wang W; Zhang L; Li S; Li C; Yang Y; Chang J; Chen T
    Nature; 2022 Jan; 601(7891):118-124. PubMed ID: 34912121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels of miRNA-21-5p in vitiligo patients and effects of miRNA-21-5p on SOX5, beta-catenin, CDK2 and MITF protein expression in normal human melanocytes.
    Aguennouz M; Guarneri F; Oteri R; Polito F; Giuffrida R; Cannavò SP
    J Dermatol Sci; 2021 Jan; 101(1):22-29. PubMed ID: 33176966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.
    Dey-Rao R; Sinha AA
    Genes Immun; 2016; 17(1):30-45. PubMed ID: 26562080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of dermal fibroblasts in autoimmune skin diseases.
    Shi Z; Liu Z; Wei Y; Zhang R; Deng Y; Li D
    Front Immunol; 2024; 15():1379490. PubMed ID: 38545113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo.
    Laberge G; Mailloux CM; Gowan K; Holland P; Bennett DC; Fain PR; Spritz RA
    Pigment Cell Res; 2005 Aug; 18(4):300-5. PubMed ID: 16029422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The genetics of generalized vitiligo.
    Spritz RA
    Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases.
    Yang SC; Alalaiwe A; Lin ZC; Lin YC; Aljuffali IA; Fang JY
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current insight into the roles of microRNA in vitiligo.
    Yan S; Shi J; Sun D; Lyu L
    Mol Biol Rep; 2020 Apr; 47(4):3211-3219. PubMed ID: 32086720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomal miRNAs in autoimmune skin diseases.
    Zhang R; Wei Y; Wang T; Nie X; Shi Z; Deng Y; Li D
    Front Immunol; 2023; 14():1307455. PubMed ID: 38106405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.
    Domingo S; Solé C; Moliné T; Ferrer B; Cortés-Hernández J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33321931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in vitiligo: Update on therapeutic targets.
    Feng Y; Lu Y
    Front Immunol; 2022; 13():986918. PubMed ID: 36119071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case of Colocalized Vitiligo and Psoriasis.
    Langley AR; Manley P; Asai Y
    J Cutan Med Surg; 2016; 20(2):150-2. PubMed ID: 26512071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentially expressed microRNAs in peripheral blood mononuclear cells of non-segmental vitiligo and their clinical significance.
    Zhang Z; Yang X; Liu O; Cao X; Tong J; Xie T; Zhang J; Peng Y
    J Clin Lab Anal; 2021 Feb; 35(2):e23648. PubMed ID: 33169883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms altering microRNA activity in psoriasis--a key to solve the puzzle of missing heritability?
    Pivarcsi A; Ståhle M; Sonkoly E
    Exp Dermatol; 2014 Sep; 23(9):620-4. PubMed ID: 24917490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNA-559 and MTDH as possible diagnostic markers of psoriasis: Role of PTEN/AKT/FOXO pathway in disease pathogenesis.
    Aldabbas R; Shaker OG; Ismail MF; Fathy N
    Mol Cell Biochem; 2023 Jul; 478(7):1427-1438. PubMed ID: 36348199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.